Home  |  Contact

ProtParam

User-provided sequence:

        10         20         30         40         50         60 
MEHRYNVFND TPRGNHWMGS SVSGSPRPSY SSRPNVNTTR RFQYSDDEPA EKIRPLRSRS

70 80 90 100 110 120
FKSTESNISD EKSRISERDS KDRYINGDKK VDIYSLPLIS TDVLEISKQR TFAVILFLII

130 140 150 160 170 180
QCYKIYDLVI LKSGLPLSGL LFKNYRFNFI SKYFIIDSFF LYVLPSFNIP RLTFKPWVVY

190 200 210 220 230 240
LQILAMLLLN IFISSDHEFV LISLIMTTWR KLYTKELSVT GSAINHHRIF DSSAHFKGAL

250 260 270 280 290 300
TIKILPENTA MFNPLHESYC LPMDTNLFKI NSIDVPIRIN STEEIEYIEL EYRDLYTNSV

310 320 330 340 350 360
ELRSLSKKDF KIIDNPKSFL KKDQSVLKSH SNDFEEGSTI RYLAVTLQDI GFYQIKKIVD

370 380 390 400 410 420
SKKLNLKIHQ SHLVVPYCPI ASITGTGSND RCIGDSDNVS FEIQGVPPMK LAYSKIVNGQ

430 440 450 460 470 480
TFSYVDSSLQ PEYFESPLQS SKSKQSFTQG ELNDLKWGRN QPVNINLDSS ITQDGKFAYK

490 500 510 520 530 540
IDKITDGLGN VVDFTSLPEE LKKRYDLSYN FNVHEVPRAA LEERFDPKSP TKRSIAIVFE

550 560 570 580 590 600
EIKNWISDIP YVISLSYTDA QDKSKKIMNV TTDSLTKVLQ ADLPGSYNLE YIESKFCPGE

610 620 630 640 650 660
IVGKSNVLVT MPVAPTMEVK SFPILDQCVG QVGLNFELSF TGAPPYYYNT KIYKLENGER

670 680 690 700 710 720
KLYDAKRYTS EGTRNRFSYS PPKEGNYEIV FDTVSNKLFT EPIKLEPVKE YTFKTSMRVK

730 740 750 760 770 780
PSASLKLHHD LKLCLGDHSS VPVALKGQGP FTLTYDIIET FSSKRKTFEI KEIKTNEYVI

790 800 810 820 830 840
KTPVFTTGGD YILSLVSIKD STGCVVGLSQ PDAKIQVRRD IPSAAFNFFE PIKEAKIKHG

850 860 870 880 890 900
SVTEIPLKLS GEGPFTVKFK HMDYDGNIVK EFENKFQNSY KPALKVSKEG LYQLVDIRDS

910 920 930 940 950 960
SCQGNVIYRN SLYKVSFLEK PKFAIQDNHH ITKVTENLFS KEEVCQGMEG TVDLALFGSP

970 980 990 1000 1010 1020
PFILEYDLMA PNGHISTKKI QVATKYASLK LPNQIPGEYI TTIKAIFDGN YGESDIHFRE

1030 1040 1050 1060 1070 1080
HQSELIIKQT VHPIPDVAFA DGGKTLRACA ANVDQISFLE PINLKFLQGE SPFSITFSVY

1090 1100 1110 1120 1130 1140
HESTSRTDQY TIDNIDSENF SFEKLYEGMK LGNHAITIDS VVDANGCVNS LISGPRNQIL

1150 1160 1170 1180 1190 1200
VSITDAPKIH ILDPSTEYCV GDYVAYQLNG VAPFMIKYEF NGIPLKSKER SSQFVRLASE

1210 1220 1230 1240 1250 1260
PGIISITSLQ DSSSQCIVDF TNPKLKSEFD DLSLNIHPIP SVTVSQGNYV TEDIREGDQA

1270 1280 1290 1300 1310 1320
EVIFSFEGTP PFSLTYVRTE ETDGKHGKRR SQVVETHKVT DIYSHEYKVI TSLQGTYEAI

1330
EITDAYCFAK NDLFFNN


References and documentation are available.

Number of amino acids: 1337 Molecular weight: 151652.55 Theoretical pI: 6.29
Amino acid composition: 
Ala (A) 47 3.5% Arg (R) 47 3.5% Asn (N) 69 5.2% Asp (D) 79 5.9% Cys (C) 15 1.1% Gln (Q) 44 3.3% Glu (E) 85 6.4% Gly (G) 66 4.9% His (H) 29 2.2% Ile (I) 114 8.5% Leu (L) 108 8.1% Lys (K) 106 7.9% Met (M) 16 1.2% Phe (F) 76 5.7% Pro (P) 70 5.2% Ser (S) 134 10.0% Thr (T) 80 6.0% Trp (W) 5 0.4% Tyr (Y) 63 4.7% Val (V) 84 6.3% Pyl (O) 0 0.0% Sec (U) 0 0.0% (B) 0 0.0% (Z) 0 0.0% (X) 0 0.0%
Total number of negatively charged residues (Asp + Glu): 164 Total number of positively charged residues (Arg + Lys): 153 Atomic composition: Carbon C 6857 Hydrogen H 10668 Nitrogen N 1760 Oxygen O 2056 Sulfur S 31 Formula: C6857H10668N1760O2056S31 Total number of atoms: 21372 Extinction coefficients: Extinction coefficients are in units of M-1 cm-1, at 280 nm measured in water. Ext. coefficient 122245 Abs 0.1% (=1 g/l) 0.806, assuming all pairs of Cys residues form cystines Ext. coefficient 121370 Abs 0.1% (=1 g/l) 0.800, assuming all Cys residues are reduced Estimated half-life: The N-terminal of the sequence considered is M (Met). The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro). >20 hours (yeast, in vivo). >10 hours (Escherichia coli, in vivo). Instability index: The instability index (II) is computed to be 36.28 This classifies the protein as stable. Aliphatic index: 86.49 Grand average of hydropathicity (GRAVY): -0.324